Abstract
Background: Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) is associated with a high risk of adverse events, but few data are available on clinical outcomes after SVG PCI with contemporary drug-eluting stents (DES), and no studies have addressed the impact of high platelet
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
